NCT00488007

Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids

Clinical Trial on Cognitive, Behavioural, Quality of Life and Medico-economic Benefits of Hearing Aids in Alzheimer Disease Patients Suffering From Presbycusis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 51 (actual)
• Sponsor: Hospices Civils de Lyon · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Not accepted

Summary

This is a 12-months' randomized clinical trial that aims at studying the benefit of bilateral hearing aids in hearing impaired patients suffering from a slight to moderate stage Alzheimer disease. The benefit of this intervention will be studied in the cognitive, behavioural, quality of life and economic fields. 2groups are involved in this trial: Intervention group: 12 months' treatment with active hearing aids, fitted hearing impairment Control group: 6 months' treatment with placebo hearing aids, followed with 6 months' active hearing aids, fitted hearing impairment

Conditions

• Alzheimer Disease
• Presbycusis

Interventions

Type	Name	Description
DEVICE	Hearing aids used : PHONAK Savia and Valeo	5 hours per day during the first 6 months (active or inactive upon randomization) 5 hours per day during the last 6 months (active)

Timeline

• Start date: 2007-05-01
• Primary completion: 2013-06-01
• Completion: 2013-09-01
• First posted: 2007-06-19
• Last updated: 2025-12-19

Locations

1 site across 1 country: France